Skip to content

Effects of hypocaloric diets at different glucose load on endothelial function and glycaemic variability in adult obese subjects with increased cardiovascular risk

Effects of hypocaloric diets at different glucose load on endothelial function and glycaemic variability in adult obese subjects with increased cardiovascular risk: a longitudinal, open-label, randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN56834511
Enrollment
80
Registered
2010-12-16
Start date
2010-11-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular and metabolic diseases

Interventions

Participants will be randomly assigned respectively to a hypocaloric low or high glucose-load diet. Both diet will have similar macronutrient composition. After three months of dieting participants wi

Sponsors

University of Palermo (Italy)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male and female subjects 2. Range of age 18 - 60 years 3. Range of body mass index (BMI) 28 - 39.9 kg/m^2 4. Presence of at least one of the diagnostic criteria of the metabolic syndrome: 4.1. Waist circumference greater than 80 cm for women and 94 cm for men 4.2. Triglycerides greater than 150 mg/dl or use of lowering blood lipid drugs 4.3. High density lipoproteins (HDL)-cholesterol less than 50 mg/dl for women or 40 mg/dl for men 4.4. Blood pressure greater than 130 mmHg for systolic or greater than 85 mmHg for diastolic blood pressure 4.5. Fasting plasma glucose greater than 100 mg/dl

Exclusion criteria

Exclusion criteria: 1. Type 1 or 2 diabetes 2. Gastro-intestinal, connective diseases 3. Chronic pancreatitis, liver cirrhosis, kidney stones, renal failure 4. Use of acetyl-salicylic acid (ASA), other antiplatelet drugs, statins, oral hypoglycemic drugs, nitrates, non-steroidal anti-inflammatory drugs (NSAIDS), corticosteroids, drugs interfering with coagulation, supplements with vitamins and anti-oxidants 5. Pregnancy or lactation in the last six months 6. Regular sport activity 7. Denial of informed consent

Design outcomes

Primary

MeasureTime frame
1. Endothelial function, measured as "flow mediated dilation" 2. Glycaemic variability, measured by the subcutaneous continuous glucose monitoring method These measurements will be obtained three times, respectively before (0 months), after hypocaloric diet (3 months) and body weight maintenance periods (12 months).

Secondary

MeasureTime frame
1. Traditional anthropometric, metabolic and cardiovascular risk factors 2. Intra-renal haemodynamic measurements (resistance and pulsatility indexes) 3. Carotid intima-media thickness These measurements will be obtained three times, respectively before (0 months), after hypocaloric diet (3 months) and body weight maintenance periods (12 months).

Countries

Italy

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 25, 2026